Ainos (NASDAQ: AIMD) inks 3-year AI Nose distribution agreement with Trusval

Rhea-AI Filing Summary

Ainos, Inc. reported that on December 30, 2025 it entered into a distribution agreement with Trusval Technology Co. Ltd. covering its AINOS AI Nose and related products and services. The agreement runs for three years and provides Trusval with one-year exclusive distribution rights for Products sold to certain clients, after which exclusivity may change according to the contract terms. This arrangement is intended to govern how Ainos’ AI Nose offerings reach designated customers through Trusval as a distributor.

Insights

Technology and Commercialization Analyst

Ainos adds a three-year distribution partner for its AI Nose products.

Ainos, Inc. has signed a three-year distribution agreement with Trusval Technology Co. Ltd. for its AINOS AI Nose and related products and services. The contract includes one-year exclusive distribution rights for Products sold to certain clients, which focuses Trusval’s role on specific customer relationships.

The agreement clarifies how these Products will be marketed and sold through Trusval but does not disclose revenue targets, minimum purchase commitments, or pricing terms in the excerpt. The one-year exclusivity for certain clients could shape sales channels during that period, with the broader three-year term framing a longer collaboration.

Overall, this is a commercial arrangements update rather than a quantified financial event, and its eventual impact will depend on how much business Trusval generates under the distribution rights during the three-year term.

false 0001014763 0001014763 2025-12-30 2025-12-30 0001014763 AIMD:CommonStockParValue0.01PerShareMember 2025-12-30 2025-12-30 0001014763 AIMD:WarrantsToPurchaseCommonStockMember 2025-12-30 2025-12-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 30, 2025

AINOS, INC.

(Exact name of registrant as specified in its charter)

Texas		001-41461		75-1974352
(State or other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

3050 Post Oak Blvd, Suite 510-T80,

Houston, TX 77056

(281) 898-6586

(Address and telephone number, including area code, of registrant’s principal executive offices)

8880 Rio San Diego Drive, Ste. 800,

San Diego, CA 92108

(858) 869-2986

(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		AIMD		The Nasdaq Stock Market LLC
Warrants to purchase Common Stock		AIMDW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On December 30, 2025, Ainos, Inc. (the “Company”), a Texas corporation, entered into a distribution agreement (the “Distribution Agreement”) with Trusval Technology Co. Ltd. (“Trusval”), pursuant to which the Company has granted distribution rights to Trusval for its AINOS AI Nose and related products and services (the “Products”). The Distribution Agreement has a three-year term and grants one-year exclusive distribution rights for Products sold to certain clients.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Ainos, Inc.
Date: January 6, 2026	By:	/s/ Chun-Hsien Tsai
	Name:	Chun-Hsien Tsai
	Title:	Chief Executive Officer

FAQ

What new agreement did Ainos (AIMD) disclose in this 8-K filing?

Ainos, Inc. disclosed that it entered into a distribution agreement with Trusval Technology Co. Ltd. covering its AINOS AI Nose and related products and services.

What products are covered by Ainos (AIMD) in the Trusval distribution agreement?

The agreement covers Ainos’ AINOS AI Nose and related products and services, collectively referred to as the Products.

How long is the term of the Ainos (AIMD) distribution agreement with Trusval?

The Distribution Agreement has a three-year term, setting the duration of the commercial relationship between Ainos and Trusval for the Products.

Does the Ainos (AIMD) agreement provide exclusivity to Trusval?

Yes. The agreement grants Trusval one-year exclusive distribution rights for Products sold to certain clients during that period.

Is there any financial information disclosed about the Ainos (AIMD) and Trusval distribution deal?

The excerpt describes the term and exclusivity of the distribution agreement but does not include specific financial terms such as revenue amounts or minimum purchase commitments.

Where is Ainos, Inc. headquartered according to the filing?

Ainos lists an address at 3050 Post Oak Blvd, Suite 510-T80, Houston, TX 77056 as its principal executive offices in the filing.